Journal article
Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice.
- Abstract:
-
It has been established that a total of 250 microg of monoclonal anti-mouse CD3 F(ab')(2) fragments, administered daily (50 microg per dose), induces remission of diabetes in the non-obese diabetic (NOD) mouse model of autoimmune diabetes by preventing beta cells from undergoing further autoimmune attack. We evaluated lower-dose regimens of monoclonal anti-CD3 F(ab')(2) in diabetic NOD mice for their efficacy and associated pharmacodynamic (PD) effects, including CD3-T-cell receptor (TCR) com...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Immunology
- Volume:
- 130
- Issue:
- 1
- Pages:
- 103-113
- Publication date:
- 2010-05-01
- DOI:
- EISSN:
-
1365-2567
- ISSN:
-
0019-2805
- Source identifiers:
-
45922
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:45922
- UUID:
-
uuid:2aa746fa-6758-4847-b90a-998492be87de
- Local pid:
- pubs:45922
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2010
If you are the owner of this record, you can report an update to it here: Report update to this record